Barton Investment Management raised its position in Cigna Corporation (NYSE:CI) by 9.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,425 shares of the health services provider’s stock after acquiring an additional 300 shares during the period. Cigna Corporation comprises approximately 0.2% of Barton Investment Management’s holdings, making the stock its 28th largest holding. Barton Investment Management’s holdings in Cigna Corporation were worth $640,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of CI. Vanguard Group Inc. raised its holdings in shares of Cigna Corporation by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after buying an additional 424,469 shares in the last quarter. BlackRock Inc. raised its holdings in shares of Cigna Corporation by 2,335.5% in the 1st quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. State Street Corp raised its holdings in shares of Cigna Corporation by 1.7% in the 1st quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock worth $1,631,451,000 after buying an additional 190,323 shares in the last quarter. FMR LLC raised its holdings in shares of Cigna Corporation by 6.7% in the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after buying an additional 432,978 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Cigna Corporation by 40.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after buying an additional 1,184,632 shares in the last quarter. 88.23% of the stock is owned by hedge funds and other institutional investors.
In related news, insider Jason D. Sadler sold 37,756 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $176.16, for a total value of $6,651,096.96. Following the sale, the insider now owns 47,844 shares in the company, valued at approximately $8,428,199.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the company’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Insiders sold a total of 45,696 shares of company stock worth $8,070,481 in the last 90 days. 1.30% of the stock is currently owned by company insiders.
WARNING: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2017/11/01/barton-investment-management-purchases-300-shares-of-cigna-corporation-ci.html.
A number of equities analysts have recently issued reports on the company. BMO Capital Markets assumed coverage on Cigna Corporation in a report on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price for the company. Jefferies Group LLC increased their price target on Cigna Corporation from $201.00 to $221.00 and gave the stock a “buy” rating in a research report on Friday, October 13th. Zacks Investment Research upgraded Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price target on the stock in a research report on Monday, October 9th. Piper Jaffray Companies restated a “buy” rating and set a $191.00 price target on shares of Cigna Corporation in a research report on Sunday, September 17th. Finally, BidaskClub upgraded Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Cigna Corporation currently has an average rating of “Buy” and an average target price of $193.44.
Shares of Cigna Corporation (NYSE CI) traded down 0.08% on Wednesday, reaching $197.06. The company’s stock had a trading volume of 625,510 shares. The company has a market cap of $49.62 billion, a PE ratio of 22.74 and a beta of 0.43. The firm has a 50 day moving average of $188.66 and a 200 day moving average of $174.04. Cigna Corporation has a 52-week low of $115.45 and a 52-week high of $202.50.
Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same quarter in the prior year, the business posted $1.98 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. Analysts predict that Cigna Corporation will post $10.03 earnings per share for the current year.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.